mained poor -.Alreadyatthetime ofdiag,nsis, most patients have distant metastases or are otherwise not fit for major surgery J.,o. For those whose tumour is considered resectable, the operative approach has been a matter of discussion, and both subtotal and total pancreatectomy have been advocated 5,8-16. Insufficiency ofa pancreato-digestive anastomosis is a common and frequently lethal complication after pancreatic, surerY.6.;a 7-20because of leakage of pancreatic secretion with" abscess and/or fistula formation Therefore, attempts to improve the results of partial pancreatectomy must be directed towards this weakness of the operative procedure. Several 
PATIENTS
During a 2 year period, July 1985-June 1987, a total of69 patients with newly diagnosed carcinoma of the exocrine pancreatic head (n 56), the ampulla ofVater (n 8), or the distal choledochal duct (n 5) were treated at the Department of Surgery in Lund. Of these, 26 patients (38%) were considered to have a resectable tumour and underwent subtotal pancreatectomy with duodenectomy. Seventeen patients had carcinoma ofthe pancreatic head, 7 had cancer of the Vaterian papilla, and 2 had a choledochal carcinoma. The men age of the resected patients was 6310 (SD) years (range 40-80 years). The operation was considered radical if as judged after the operation all malignant tissue had been removed. Otherwise, the operation was considered to be palliative.
OPERATIVE PROCEDURE
The operation starts with extensive dissection of the retroduodenal region, the inferior vena cava from above the left renal vein and 10 cm downward, and ofthe hepatoduodenal and gastrohepatic ligaments. The gallbladder is excised. All tissue but the major arteries, the portal vein and the bile ducts, are removed from the hilum ofthe liver down to the origin of the coeliac artery. All identifiable lymph glands are sent for separate histologic examination. The coeliac plexus is included in the resection. The pancreas is divided with stapler above the portal vein. The pancreas to the right of the portal vein is removed together with the duodenum, adjacent retroperitoneal tissue, two thirds of the stomach, the proximal jejunum and the extrahepatic biliary tree approximately one cm below the junction of the hepatic ducts. Care is taken to remove all tissue on the posterior and right sides of the superior mesenteric and portal veins and the superior mesenteric artery, from the hilum of the liver and the aorta, respectively, down to the first jejunal branches. About half of the remaining pancreas (approximately the body) is dissected from the splenic vessels before the pancreas is again stapled off, with a TA55 instrument (the first 14 patients in the series) or RL60 (the last 12 patients in the series), 6-7 cm from the end of the tail. In addition, the pancreatic duct is suture-ligated and, in some cases, a running 2-0 Prolene suture is used to reinforce the closure ofthe severed end of the pancreas. Hepatojejunostomy is fashioned with a 60 cm jejunal Roux-en-Yloop end to side and followed gastrojejunostomy to the posterior or anterior side of the stomach; the end of the Roux loop is placed subcutaneously. A separate incision was made for placement of a rubber drain down to the peripancreatic area.
FOLLOW UP
The patients have been regularly followed by the operating surgeon. The last patient in this series has been followed now for 14 Ranitidine (Zantac), widely used postoperatively as a hydrogen ion blocker, has been observed experimentally to retard gastric emptying in man. Reglan, utilized to promote gastric motility, has not solved the problem.
Meanwhile, all of our related patients have baseline radionuclear scans of gastric emptying preoperatively and serially postoperatively, utilizing scrambled eggs orally into which is mixed a technicum 99 sulphur colloid. Transient, but troublesome postoperative gastric stasis is frequent. Although gastric atony is obviously a factor, no study has yet proved whether the fundamental problem has a technical or physiological basis.
INVITED COMMENTARY
The paper by Ahren and others shows once again that pancreatoduodenectomy for cancer can be performed with low mortality. In the last decade hospital mortality after this procedure has decreased below 5%2, and mortality of more than 10% is regarded as unacceptable. One should be aware that most reports, such as the one by Ahren et al come from well-known centres, with special interest and experience in pancreatic surgery, and although excellent results can be achieved by the occasional 'laancreatectomist ''3, it is fair to say that the results ofmost unpublished series are not as good.
Hospital mortality is generally considered to bethe yardstick of surgical quality, but morbidity and long-term sequellae may be just as important since they affect to a large extent the quality of life after pancreatoduodenectomy. Serious postoperative complications are frequent and occur in about 30%, leading to reoperations, long hospitalisation and high costs4. Breakdown of the pancreato-enteric anastomosis is the most feared complication that occurs in about 12%J. 
